The problem of magnesium deficiency and metabolic syndrome
https://doi.org/10.33667/2078-5631-2023-8-48-52
Abstract
The epidemic of obesity, insulin resistance and diabetes mellitus currently observed in developed countries requires new approaches to the prevention and treatment. Besides the hypercaloric diet micronutrient deficiency is involved in the development of metabolic disorders. Recent diet changes due to the agrarian and food technological revolutions has led to the emergence of new micronutrient deficiencies, primarily magnesium. While its hypotonic action is well studied, magnesium’s positive effects on metabolism, anti-inflammatory and antioxidant effects are currently the focus of researchers’ attention. The magnesium preparations reduce insulin resistance, improves anthropometric and laboratory markers of the metabolic syndrome. Detection of magnesium deficiency, including subclinical one, and correction of magnesium status are important tasks for the prevention and complex therapy of the metabolic syndrome. Given the higher bioavailability and lower incidence of side effects, organic magnesium salts are preferable.
About the Authors
E. A. Nikitina
Peoples’ Friendship University of Russia; Scientific and Practical Center for Child Psychoneurology, Moscow Department of Health
Russian Federation
Russian Federation
Nikitina Elena A., PhD Med, assistant professor of Dept of Dietetics and Clinical Nutritiology, Researcher
Moscow
S. V. Orlova
Peoples’ Friendship University of Russia; Scientific and Practical Center for Child Psychoneurology, Moscow Department of Health
Russian Federation
Russian Federation
Orlova Svetlana V., DM Sci (habil.), professor, head of Dept of Dietetics and Clinical Nutritiology, Chief Researcher
Moscow
N. V. Balashova
Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
Balashova Natalya V., PhD Bio Sci, assistant of Dept of Dietetics and Clinical Nutritiology
Moscow
Yu. A. Pigareva
City Clinical Hospital n. a. V. V. Vinogradov
Russian Federation
Russian Federation
Pigareva Yulia A., PhD Med, head of Dept of Clinical Dietetics
Moscow
References
1. Kytikova OY, Antonyuk MV, Kantur TA, Novgorodtseva TP, Denisenko YK. Prevalence and biomarkers in metabolic syndrome. Obesity and metabolism. 2021;18(3):302–312. DOI: https://doi.org/10.14341/omet12704
2. Clinical guidelines. Obesity. Approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. Year of approval 2020. https://cr.minzdrav. gov.ru/schema/28_2
3. Algorithms of specialized medical care for patients with diabetes mellitus. Edited by I. I. Dedova, M. V. Shestakova, A. Yu. Mayorova. – 10th edition (updated). – M., 2021. DOI: https://doi.org/10.14341/DM12802
4. WHO News. More than 700 million people with untreated hypertension. https://www.who.int/ru/news/item/25–08–2021-more-than-700-million-people-with-untreated-hypertension.
5. Romani AMP. Beneficial Role of Mg2+ in Prevention and Treatment of Hypertension. Int J. Hypertens. 2018 Jun 11;2018:9013721. DOI: 10.1155/2018/9013721
6. Ismail Y, Ismail AA, Ismail AA. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for «normal» results. Clin. Chem. Lab. Med. 2010 Mar;48(3):323–7. DOI: 10.1515/CCLM.2010.077
7. Srinutta T, Chewcharat A, Takkavatakarn K, Praditpornsilpa K, Eiam-Ong S, Jaber BL, Susantitaphong P. Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies. Medicine (Baltimore). 2019 Nov;98(44): e17788. DOI: 10.1097/MD.0000000000017788
8. Wakeman M, Archer DT. Metformin and Micronutrient Status in Type 2 Diabetes: Does Polypharmacy Involving Acid-Suppressing Medications Affect Vitamin B 12 Levels? Diabetes Metab Syndr Obes. 2020 Jun 18;13:2093–2108. DOI: 10.2147/DMSO.S237454
9. Clinical guide to laboratory tests by Tietz Norbert W., Translation from English. (4th edition Elsevier, 2006). М.: Labora, 2013.
10. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch. Intern. Med. 1999 Oct 11;159(18):2151–9. DOI: 10.1001/archinte.159.18.2151.
11. Ismail AAA, Ismail Y, Ismail AA. Chronic magnesium deficiency and human disease; time for reappraisal? QJM. 2018 Nov 1;111(11):759–763. DOI: 10.1093/qjmed/hcx186
12. Catalano A, Bellone F, Chilà D, Loddo S, Corica F. Magnesium disorders: Myth or facts? Eur. J. Intern. Med. 2019 Dec;70: e22–e24. DOI: 10.1016/j.ejim.2019.10.013
13. Schutten JC, Joosten MM, de Borst MH, Bakker SJL. Magnesium and Blood Pressure: A Physiology-Based Approach. Adv Chronic Kidney Dis. 2018 May;25(3):244–250. DOI: 10.1053/j.ackd.2017.12.003
14. Han H, Fang X, Wei X, Liu Y, Jin Z, Chen Q, Fan Z, Aaseth J, Hiyoshi A, He J, Cao Y. Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies. Nutr. J. 2017 May 5;16(1):26. DOI: 10.1186/s12937–017–0247–4
15. Rosanoff A, Costello RB, Johnson GH. Effectively Prescribing Oral Magnesium Therapy for Hypertension: A Categorized Systematic Review of 49 Clinical Trials. Nutrients. 2021 Jan 10;13(1):195. DOI: 10.3390/nu13010195
16. Guerrero-Romero F, Jaquez-Chairez FO, Rodríguez-Morán M. Magnesium in metabolic syndrome: a review based on randomized, double-blind clinical trials. Magnes Res. 2016 Apr 1;29(4):146–153. DOI: 10.1684/mrh.2016.0404
17. Pelczyńska M, Moszak M, Bogdański P. The Role of Magnesium in the Pathogenesis of Metabolic Disorders. Nutrients. 2022 Apr 20;14(9):1714. DOI: 10.3390/nu14091714
18. Kostov K. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. Int J. Mol. Sci. 2019 Mar 18;20(6):1351. DOI: 10.3390/ijms20061351
19. Kolisek M, Montezano AC, Sponder G, Anagnostopoulou A, Vormann J, Touyz RM, Aschenbach JR. PARK7/DJ-1 dysregulation by oxidative stress leads to magnesium deficiency: implications in degenerative and chronic diseases. Clin. Sci. (Lond). 2015 Dec;129(12):1143–50. DOI: 10.1042/CS 20150355
20. Zhao B, Deng H, Li B, Chen L, Zou F, Hu L, Wei Y, Zhang W. Association of magnesium consumption with type 2 diabetes and glucose metabolism: A systematic review and pooled study with trial sequential analysis. Diabetes Metab. Res Rev. 2020 Mar;36(3): e3243. DOI: 10.1002/dmrr.3243
21. Oost LJ, Tack CJ, de Baaij JHF. Hypomagnesemia and Cardiovascular Risk in Type 2 Diabetes. Endocr Rev. 2022 Nov 8: bnac028. DOI: 10.1210/endrev/bnac028
22. Moore-Schiltz L, Albert JM, Singer ME, Swain J, Nock NL. Dietary intake of calcium and magnesium and the metabolic syndrome in the National Health and Nutrition Examination (NHANES) 2001–2010 data. Br. J. Nutr. 2015 Sep 28;114(6):924–35. DOI: 10.1017/S0007114515002482
23. Askari M, Mozaffari H, Jafari A, Ghanbari M, Darooghegi Mofrad M. The effects of magnesium supplementation on obesity measures in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit. Rev Food Sci. Nutr. 2021;61(17):2921–2937. DOI: 10.1080/10408398.2020.1790498.
24. Rafiee M, Ghavami A, Rashidian A, Hadi A, Askari G. The effect of magnesium supplementation on anthropometric indices: a systematic review and dose-response meta-analysis of clinical trials. Br. J. Nutr. 2021 Mar 28;125(6):644–656. DOI: 10.1017/S0007114520003037
25. Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M, Zambrano-Galvan G, Guerrero-Romero F. Effect of Magnesium Supplementation on Plasma C-reactive Protein Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr. Pharm Des. 2017;23(31):4678–4686. DOI: 10.2174/1381612823666170525153605.
26. Spasov A. A., Petrov V. I., Iezhitsa I. N., Kravchenko M. S., Kharitonova M. V., Ozerov A. A. Comparative pharmacological activity of organic and inorganic magnesium salts in conditions of systemic alimentary hypomagnesemia. Bulletin of the Russian Academy of Medical Sciences. 2010; 2:29–37.
27. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington (DC): National Academies Press (US); 1997. PMID: 23115811.
Review
For citations:
Nikitina E.A., Orlova S.V., Balashova N.V., Pigareva Yu.A. The problem of magnesium deficiency and metabolic syndrome. Medical alphabet. 2023;(8):48-52. (In Russ.) https://doi.org/10.33667/2078-5631-2023-8-48-52
Views:
528
Email this article 